Publications
- Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Limited efficacy of daratumumab in multiple myeloma with extramedullary disease2022 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Identification of patients at high risk of secondary extramedullary multiple myeloma development2022 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma2021 | Faculty of Medicine in Hradec Králové
- Simplified novel prognostic score for real-life older adults with multiple myeloma-registry-based analysis2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome2019 | Faculty of Medicine in Pilsen
- Comparison of autologous hematopoietic cell transplantation performed in tandem and in disease relapse in multiple myeloma patients2018 | Publication without faculty affiliation
- Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation2017 | Publication without faculty affiliation
- Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...
